First PREMIER Bank trimmed its position in shares of CSX Co. (NASDAQ:CSX – Free Report) by 3.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 79,237 shares of the transportation company’s stock after selling 2,904 shares during the period. First PREMIER Bank’s holdings in CSX were worth $2,557,000 as of its most recent SEC filing.
A number of other hedge funds also recently bought and sold shares of CSX. Valley Wealth Managers Inc. raised its stake in shares of CSX by 177.8% during the third quarter. Valley Wealth Managers Inc. now owns 750 shares of the transportation company’s stock worth $26,000 after acquiring an additional 480 shares in the last quarter. Morton Brown Family Wealth LLC bought a new position in shares of CSX during the 3rd quarter valued at $31,000. Addison Advisors LLC grew its holdings in shares of CSX by 348.5% during the 3rd quarter. Addison Advisors LLC now owns 1,045 shares of the transportation company’s stock valued at $36,000 after purchasing an additional 812 shares during the last quarter. Fortitude Family Office LLC raised its position in CSX by 43.4% in the 3rd quarter. Fortitude Family Office LLC now owns 1,110 shares of the transportation company’s stock worth $38,000 after purchasing an additional 336 shares during the period. Finally, Jamison Private Wealth Management Inc. lifted its stake in CSX by 33.7% in the third quarter. Jamison Private Wealth Management Inc. now owns 1,253 shares of the transportation company’s stock worth $43,000 after purchasing an additional 316 shares during the last quarter. Institutional investors own 73.57% of the company’s stock.
Analyst Ratings Changes
A number of research analysts have recently issued reports on the company. Susquehanna reduced their price objective on CSX from $40.00 to $39.00 and set a “positive” rating on the stock in a research note on Wednesday, January 8th. BMO Capital Markets decreased their price target on CSX from $40.00 to $39.00 and set an “outperform” rating on the stock in a research note on Thursday, October 17th. Citigroup increased their price objective on CSX from $42.00 to $44.00 and gave the company a “buy” rating in a research note on Tuesday, November 12th. Wells Fargo & Company cut their target price on shares of CSX from $35.00 to $34.00 and set an “equal weight” rating on the stock in a report on Thursday, October 17th. Finally, TD Cowen lowered their price target on shares of CSX from $36.00 to $35.00 and set a “hold” rating for the company in a report on Thursday, October 17th. Six analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $38.65.
CSX Stock Down 0.1 %
Shares of NASDAQ:CSX opened at $33.24 on Thursday. The firm has a market capitalization of $64.10 billion, a P/E ratio of 17.87, a P/E/G ratio of 2.05 and a beta of 1.22. The company has a debt-to-equity ratio of 1.43, a quick ratio of 1.23 and a current ratio of 1.39. The stock has a 50 day moving average price of $33.69 and a 200-day moving average price of $33.95. CSX Co. has a 52-week low of $31.43 and a 52-week high of $40.12.
About CSX
CSX Corporation, together with its subsidiaries, provides rail-based freight transportation services. The company offers rail services; and transportation of intermodal containers and trailers, as well as other transportation services, such as rail-to-truck transfers and bulk commodity operations. It also transports chemicals, agricultural and food products, minerals, automotive, forest products, fertilizers, and metals and equipment; and coal, coke, and iron ore to electricity-generating power plants, steel manufacturers, and industrial plants, as well as exports coal to deep-water port facilities.
Read More
- Five stocks we like better than CSX
- Using the MarketBeat Dividend Yield Calculator
- 2 ETFs to Maximize Gains With Covered Call Strategies
- 3 Ways To Invest In Coffee, Other Than Drinking It
- 3 Small-Cap Stocks Insiders and Institutions Are Buying
- What Are Dividend Champions? How to Invest in the Champions
- MaxCyte: Building the Future of Cell and Gene Therapy Innovation
Receive News & Ratings for CSX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSX and related companies with MarketBeat.com's FREE daily email newsletter.